Aardvark Therapeutics, Inc. Common Stock
AARD •
Sell Closed
Signal type
Sell
Status
Closed
Open Price
$12.43
Closed Price
$4.64
Performance
62.66%
Days Open
74
Signal Setup
Signal Type Sell
Status Closed
Open Date Jan 30, 2026
Open Price $12.43
Stop Loss $14.79
Timespan Day
Trade Outcome
Closed Status Profit
Closed Date Apr 14, 2026
Closed Price $4.64
Performance 62.66%
Days Open 74
Company Profile
Name Aardvark Therapeutics, Inc. Common Stock
Ticker AARD
Market Cap $293.22M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $4.64
List Date Feb 13, 2025
Description
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
Website Open Company Website